Home » Topics » Regulatory

Regulatory
RSS

European approval for Protelos

Oct. 6, 2004

Abilify approved for acute bipolar mania

Oct. 5, 2004

FDA approves Remicade as first-line therapy in moderate to severe RA

Oct. 5, 2004

Enbrel approved in E.U. for psoriasis

Oct. 5, 2004

Third indication studied for SGN-30 in new phase II trial

Sep. 29, 2004

Expanded indication for Eloxatin for early stage colon cancer treatment

Sep. 21, 2004

Nexium completes European mutual recognition procedure for new indications

Sep. 20, 2004

Vioxx approved for once-daily treatment of juvenile rheumatoid arthritis

Sep. 9, 2004

Proscar approved for new indication in Canada

Sep. 7, 2004

Clarinex syrup approved for use in children with allergies, hives

Sep. 3, 2004